logo-loader

OptiBiotix Health aiming to be big in Japan with latest deal

Published: 15:39 11 Feb 2019 GMT

Following hard on the heels of a commercial deal covering the Baltic area, OptiBiotix Health plc (LON:OPTI) has signed an agreement that will see its breakthrough cholesterol-lowering bacteria strain distributed in Japan. Founder and CEO Stephen O'Hara talks Proactive London through OptiBiotix's last two RNS's and explains how they are inter-related. O'Hara also explains how he has an eye for an emerging trend and how this product, in his view, is one of those key moments.
For the UK group has negotiated an exclusive tie-up with the EIWA Trading Co for its LPLDL product. OptiBiotix will ship an agreed minimum volume of the cholesterol and blood pressure-reducing probiotic, Lactobacillus plantarum, which rises over the term of the three-year contract.

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

17 minutes ago